Trials / Completed
CompletedNCT02179749
Mifepristone Treatment of Alcohol Use Disorder
Glucocorticoid Antagonist Treatment of Alcohol Use Disorder
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 103 (actual)
- Sponsor
- The Scripps Research Institute · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This is an 8-week, randomized, double-blind, placebo-controlled, 2 arm, parallel groups, study of 1-week of treatment with mifepristone (0, 1200 mg/d) given in conjunction with 8 weeks of manual-guided counseling, and a follow-up visit at Week 12.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Mifepristone 1200 mg daily | Mifepristone, 300 mg tablets, Four tablets daily/am for 1-week duration. |
| BEHAVIORAL | Standardized behavioral therapy | Standardized behavioral therapy 1 time per week for 8 week duration. |
| DRUG | Placebo | Placebo tablets, Four tablets daily/am for 1-week duration. |
Timeline
- Start date
- 2014-09-01
- Primary completion
- 2019-11-01
- Completion
- 2019-11-06
- First posted
- 2014-07-02
- Last updated
- 2022-10-06
- Results posted
- 2022-10-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02179749. Inclusion in this directory is not an endorsement.